Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

@article{Goh2007SubtrochantericIF,
  title={Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.},
  author={S. Goh and K. Y. Yang and J. Koh and M. K. Wong and S. Chua and D. Chua and T. Howe},
  journal={The Journal of bone and joint surgery. British volume},
  year={2007},
  volume={89 3},
  pages={
          349-53
        }
}
We carried out a retrospective review over ten months of patients who had presented with a low-energy subtrochanteric fracture. We identified 13 women of whom nine were on long-term alendronate therapy and four were not. The patients treated with alendronate were younger, with a mean age of 66.9 years (55 to 82) vs 80.3 years (64 to 92) and were more socially active. The fractures sustained by the patients in the alendronate group were mainly at the femoral metaphyseal-diaphyseal junction and… Expand
486 Citations
A rational approach to management of alendronate-related subtrochanteric fractures.
  • 114
  • PDF
Subtrochanteric stress fractures in patients on oral bisphosphonate therapy: an emerging problem.
  • 12
  • PDF
Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register‐Based National Cohort Study
  • B. Abrahamsen, P. Eiken, R. Eastell
  • Medicine
  • Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 2009
  • 269
Low-Energy Femoral Shaft Fractures Associated With Alendronate Use
  • 336
  • PDF
Bisphosphonate-related subtrochanteric femoral fractures.
  • 11
Is Surgery Necessary for Femoral Insufficiency Fractures after Long-term Bisphosphonate Therapy?
  • 98
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Severely suppressed bone turnover: a potential complication of alendronate therapy.
  • 1,237
  • PDF
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.
  • 703
  • PDF
Ten years' experience with alendronate for osteoporosis in postmenopausal women.
  • 751
The diagnosis of osteoporosis
  • 2,713
Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib
  • 665
...
1
2
3
...